RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,642 | -65.0% | 944 | -74.8% | 0.00% | -50.0% |
| Q2 2023 | $61,838 | +20042.7% | 3,750 | -78.2% | 0.00% | -80.0% |
| Q1 2023 | $307 | -23.2% | 17,213 | +25.2% | 0.01% | -41.2% |
| Q4 2022 | $400 | -99.8% | 13,750 | +62.3% | 0.02% | +466.7% |
| Q3 2022 | $207,000 | +728.0% | 8,474 | +46.0% | 0.00% | +200.0% |
| Q2 2022 | $25,000 | -93.7% | 5,804 | -83.2% | 0.00% | -75.0% |
| Q1 2022 | $397,000 | +1488.0% | 34,508 | +1270.5% | 0.00% | – |
| Q4 2021 | $25,000 | -39.0% | 2,518 | -21.2% | 0.00% | -100.0% |
| Q3 2021 | $41,000 | -43.8% | 3,197 | -14.4% | 0.00% | -50.0% |
| Q2 2021 | $73,000 | +52.1% | 3,735 | +64.2% | 0.00% | +100.0% |
| Q1 2021 | $48,000 | +108.7% | 2,274 | +190.1% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -47.7% | 784 | -61.1% | 0.00% | – |
| Q3 2020 | $44,000 | -29.0% | 2,017 | -27.6% | 0.00% | -100.0% |
| Q2 2020 | $62,000 | +376.9% | 2,784 | +361.7% | 0.00% | +200.0% |
| Q3 2019 | $13,000 | -56.7% | 603 | -44.9% | 0.00% | -50.0% |
| Q1 2019 | $30,000 | +328.6% | 1,095 | +364.0% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | +600.0% | 236 | +381.6% | 0.00% | – |
| Q3 2018 | $1,000 | -92.3% | 49 | -88.4% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +62.5% | 424 | +8.2% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | – | 392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |